Stocks and Investing
Stocks and Investing
Wed, June 17, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 16, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Bednar Initiated (XRAY) at Buy and Held Target at $51 on, Jun 16th, 2020
Jason Bednar of Piper Sandler, Initiated "DENTSPLY SIRONA Inc." (XRAY) at Buy and Held Target at $51 on, Jun 16th, 2020.
Jason has made no other calls on XRAY in the last 4 months.
There are 9 other peers that have a rating on XRAY. Out of the 9 peers that are also analyzing XRAY, 5 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yi Chen of "HC Wainwright & Co." Maintained at Hold with Increased Target to $50 on, Monday, June 15th, 2020
- Paige Meyer of "CFRA" Maintained at Hold with Decreased Target to $38 on, Thursday, May 14th, 2020
- Kevin Caliendo of "UBS" Maintained at Hold with Decreased Target to $44 on, Monday, May 11th, 2020
- Steven Valiquette of "Barclays" Maintained at Hold with Decreased Target to $40 on, Monday, May 11th, 2020
- Tycho Peterson of "JP Morgan" Maintained at Hold with Decreased Target to $45 on, Tuesday, March 17th, 2020
These are the ratings of the 4 analyists that currently disagree with Jason
- Elizabeth Anderson of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $50 on, Wednesday, May 27th, 2020
- Jeff Johnson of "Baird" Upgraded from Hold to Buy and Decreased Target to $49 on, Wednesday, April 8th, 2020
- Steve Beuchaw of "Wolfe Research" Upgraded from Hold to Buy and Held Target at $66 on, Thursday, April 2nd, 2020
- Jonathan Block of "Stifel" Maintained at Strong Buy with Decreased Target to $56 on, Friday, March 13th, 2020